An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.

BACKGROUND: Adjuvant! Online is an internet-based computer programme providing 10-year prognosis predictions for early breast cancer patients. It was developed in the United States, has been successfully validated in Canada, and is used in the United Kingdom and elsewhere. This study investigates th...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Campbell, H, Taylor, M, Harris, A, Gray, A
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2009
_version_ 1826275798953230336
author Campbell, H
Taylor, M
Harris, A
Gray, A
author_facet Campbell, H
Taylor, M
Harris, A
Gray, A
author_sort Campbell, H
collection OXFORD
description BACKGROUND: Adjuvant! Online is an internet-based computer programme providing 10-year prognosis predictions for early breast cancer patients. It was developed in the United States, has been successfully validated in Canada, and is used in the United Kingdom and elsewhere. This study investigates the performance of Adjuvant! in a cohort of patients from the United Kingdom. METHODS: Data on the prognostic factors and management of 1065 women with early breast cancer diagnosed consecutively at the Churchill Hospital in Oxford between 1986 and 1996 were entered into Adjuvant! to generate predictions of overall survival (OS), breast cancer-specific survival (BCSS), and event-free survival (EFS) at 10 years. Such predictions were compared with the observed 10-year outcomes of these patients. RESULTS: For the whole cohort, Adjuvant! significantly overestimated OS (by 5.54%, P<0.001), BCSS (by 4.53%, P<0.001), and EFS (by 3.51%, P=0.001). For OS and BCSS, overestimation persisted across most demographic, pathologic, and treatment subgroups investigated. Differences between Adjuvant! predicted and observed EFS appeared smaller, and were significant for far fewer subgroups, only 5 out of the 28. The likely explanation for such discordance is that US breast cancer mortality rates (upon which Adjuvant! is based) appear to be systematically lower than breast cancer mortality rates in the United Kingdom. Differences in survival after recurrence would seem to be one contributory factor, with data suggesting that prognosis after relapse appears poorer in the United Kingdom. This may reflect the fact that new and more effective cancer drugs are often only approved for use in the United Kingdom many years after their adoption in the United States. CONCLUSION: The use of Adjuvant! by clinicians within the UK National Health Service is increasing, under the assumption that the programme is transferrable to the United Kingdom. At least for women treated for breast cancer at the Churchill Hospital in Oxford, however, Adjuvant!'s predictions were on the whole overoptimistic. If the findings reported here could be shown to be generalisable to other areas of the United Kingdom, then thought should perhaps be given to the development of a UK-specific version of the programme.
first_indexed 2024-03-06T23:04:17Z
format Journal article
id oxford-uuid:6340f49f-e4a3-44cf-ad2a-3bfd6498f91b
institution University of Oxford
language English
last_indexed 2024-03-06T23:04:17Z
publishDate 2009
record_format dspace
spelling oxford-uuid:6340f49f-e4a3-44cf-ad2a-3bfd6498f91b2022-03-26T18:11:37ZAn investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6340f49f-e4a3-44cf-ad2a-3bfd6498f91bEnglishSymplectic Elements at Oxford2009Campbell, HTaylor, MHarris, AGray, ABACKGROUND: Adjuvant! Online is an internet-based computer programme providing 10-year prognosis predictions for early breast cancer patients. It was developed in the United States, has been successfully validated in Canada, and is used in the United Kingdom and elsewhere. This study investigates the performance of Adjuvant! in a cohort of patients from the United Kingdom. METHODS: Data on the prognostic factors and management of 1065 women with early breast cancer diagnosed consecutively at the Churchill Hospital in Oxford between 1986 and 1996 were entered into Adjuvant! to generate predictions of overall survival (OS), breast cancer-specific survival (BCSS), and event-free survival (EFS) at 10 years. Such predictions were compared with the observed 10-year outcomes of these patients. RESULTS: For the whole cohort, Adjuvant! significantly overestimated OS (by 5.54%, P<0.001), BCSS (by 4.53%, P<0.001), and EFS (by 3.51%, P=0.001). For OS and BCSS, overestimation persisted across most demographic, pathologic, and treatment subgroups investigated. Differences between Adjuvant! predicted and observed EFS appeared smaller, and were significant for far fewer subgroups, only 5 out of the 28. The likely explanation for such discordance is that US breast cancer mortality rates (upon which Adjuvant! is based) appear to be systematically lower than breast cancer mortality rates in the United Kingdom. Differences in survival after recurrence would seem to be one contributory factor, with data suggesting that prognosis after relapse appears poorer in the United Kingdom. This may reflect the fact that new and more effective cancer drugs are often only approved for use in the United Kingdom many years after their adoption in the United States. CONCLUSION: The use of Adjuvant! by clinicians within the UK National Health Service is increasing, under the assumption that the programme is transferrable to the United Kingdom. At least for women treated for breast cancer at the Churchill Hospital in Oxford, however, Adjuvant!'s predictions were on the whole overoptimistic. If the findings reported here could be shown to be generalisable to other areas of the United Kingdom, then thought should perhaps be given to the development of a UK-specific version of the programme.
spellingShingle Campbell, H
Taylor, M
Harris, A
Gray, A
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
title An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
title_full An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
title_fullStr An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
title_full_unstemmed An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
title_short An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
title_sort investigation into the performance of the adjuvant online prognostic programme in early breast cancer for a cohort of patients in the united kingdom
work_keys_str_mv AT campbellh aninvestigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT taylorm aninvestigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT harrisa aninvestigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT graya aninvestigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT campbellh investigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT taylorm investigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT harrisa investigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom
AT graya investigationintotheperformanceoftheadjuvantonlineprognosticprogrammeinearlybreastcancerforacohortofpatientsintheunitedkingdom